tbuckley/cabot-search huggingface dataset:
Kruppel-Like-Factor 5 (Klf-5) Controls Hematopoietic Stem Cell/Progenitor Bone Marrow Homing and Lodging Through Rab5-Mediated Expression of Active β1 Integrin
Authors: Eri Taniguchi Ishikawa, Kyung-Hee Chang, H. Andre Olsson, Ramesh C Nayak, Ashley Ficker, Susan K Dunn, Amitava Sengupta, Jeffrey Whitsett, H. Leighton Grimes, Jose A Cancelas
Journal: Blood (2012)
The Bruton's Tyrosine Kinase (Btk) Inhibitor PCI-32765 Modulates Chronic Active BCR Signaling and Induces Tumor Regression in Relapsed/Refractory ABC DLBCL
Authors: Louis M. Staudt, Kieron Dunleavy, Joseph J. Buggy, Eric Hedrick, Nicole Lucas, Stefania Pittaluga, Sameer Jhavar, Roland Schmitz, Mickey Williams, Jason Lih, Elaine S. Jaffe, Wyndham H. Wilson
Journal: Blood (2011)
Interferon-γ-Induced Upregulation of Immunoproteasome Subunit Assembly Overcomes Bortezomib Resistance of Leukemia Cell Lines Harbouring Bortezomib-Induced Mutations in Constitutive PSMB5
Authors: Denise Niewerth, Niels Franke, Gerrit Jansen, Yehuda Assaraf, Johan van Meerloo, Christopher J Kirk, Sonja Zweegman, Gertjan J.L. Kaspers, Jacqueline Cloos
Journal: Blood (2012)
Proposed diagnostic criteria and classification of basophilic leukemias and related disorders
Authors: P Valent, K Sotlar, K Blatt, K Hartmann, A Reiter, I Sadovnik, W R Sperr, P Bettelheim, C Akin, K Bauer, T I George, E Hadzijusufovic, D Wolf, J Gotlib, F-X Mahon, D D Metcalfe, H-P Horny, M Arock
Journal: Leukemia (2017)
Post-Extrasystolic Transaortic Valve Gradients Differentiate “Pseudo” and “True” Low-Flow, Low-Gradient Severe AS During Dobutamine Stress Echocardiography
Authors: Brandon M. Wiley, Ari Pollack, Ajay S. Vaidya, Sunil K. Agarwal, Partho P. Sengupta, Farooq A. Chaudhry
Journal: JACC. Cardiovascular imaging (2017)
Mutational Profile and Karyotypic Abnormalities of a Cohort of Clinical Trial Patients with Higher-Risk Myelodysplastic Syndromes (MDS) Following Failure of Hypomethylating Agents (HMAs): Impact on Response to Rigosertib Therapy
Authors: Ghulam J Mufti, Steven Best, Nicholas Lea, Lewis R. Silverman, Guillermo Garcia-Manero, Nozar Azarnia, Francois Wilhelm, Gudrun Goehring
Journal: Blood (2014)
Aberrant Expression of Regulatory miRNAs and Transcripts for IRS-PI3K Growth and Survival Signaling In Waldenstrom's Macroglobulinemia
Authors: Zachary Hunter, Yang Cao, Megan Lewicki, Jenny Sun, Hsiuyi Tseng, Christina Hanzis, Philip Brodsky, Robert Manning, Lian Xu, Guang Yang, Yangsheng Zhou, Xia Liu, Jingrui Jiang, Christopher Patterson, Steven P. Treon
Journal: Blood (2010)
Challenges of Assessing Common Problems Presenting in Uncommon High-Risk Patient Populations
Authors: Robert C. Welsh
Journal: JAMA Cardiology (2017)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Cardiology HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Cardiology journal
Extended-Interval Prophylaxis with rFIXFc in Adults and Adolescents with Hemophilia B: Interim Results of the B-YOND Extension Study
Authors: Johnny Mahlangu, Amy D Shapiro, K John Pasi, Margaret V Ragni, Margareth Castro Ozelo, Johannes Oldenburg, Tadashi Matsushita, Ross I Baker, Huixing Yuan, Alejandra Ramirez-Santiago, Glenn F Pierce, Geoffrey Allen, Baisong Mei
Journal: Blood (2015)
Rituximab, Either As Single Agent or in Combination, Is Superior to Other Treatments in Terms of Response Rate and Progression-Free Survival (PFS) in Patients with Splenic Marginal Zone Lymphoma (SMZL)
Authors: Ana Marin-Niebla, Monica Else, Fatima De la Cruz, Paul Batty, Eduardo Rios-Herranz, Claire E. Dearden, Ildefonso Espigado, Jose Antonio Pérez Simón, Daniel Catovsky, Estella Matutes
Journal: Blood (2011)
The Clinical and PRV-1 Expression Phenotype of Wild-Type, Heterozygous, and Homozygous JAK2 V617F in Polycythemia Vera.
Authors: Ayalew Tefferi, Shireen Sirhan, Terra L. Lasho, Susan M. Schwager, Jacob S. Strand, Michelle A. Elliott, Ruben A. Mesa, Alexandra P. Wolanskyj, David P. Steensma, Chin Yang Li, Martha Wadleigh, Stephanie J. Lee, D. Gary Gilliland
Journal: Blood (2005)
In Vitro expanded STAT1−/− Regulatory T Cells Prevent Acute Graft Versus Host Disease (GVHD) and Promote Donor Cell Engraftment In Allogeneic Fully MHC-Mismatched Bone Marrow Transplant
Authors: Huihui Ma, Caisheng Lu, Judy Ziegler, Suzanne Lentzsch, Markus Y Mapara
Journal: Blood (2010)
Genome-Wide Analysis of Genetic Alterations In Hypodiploid Acute Lymphoblastic Leukemia Identifies a High Frequency of Mutations Targeting the IKAROS Gene Family and Ras Signaling
Authors: Linda Holmfeldt, Jinghui Zhang, Jing Ma, Meenakshi Devidas, Andrew J. Carroll, Nyla A. Heerema, Julie M. Gastier-Foster, Susana C. Raimondi, Mignon L. Loh, Stephen Hunger, Charles Mullighan
Journal: Blood (2010)
Academic Community Standards for Chronic Transfusion Therapy In Children with Sickle Cell Anemia and Abnormal Transcranial Doppler Velocities
Authors: Banu Aygun, Lisa Wruck, William Herbert Schultz, Isaac Odame, R. Clark Brown, William C. Owen, Brian W. Berman, Hamayun Imran, Courtney Thornburg, Michelle Neier, Kamar Godder, Stephen Nelson, Cynthia A. Gauger, Russell E. Ware, The TWITCH Investigators
Journal: Blood (2010)
Final Analysis of Induction Treatment with Fludarabine, Cyclophosphamide Plus Rituximab (FCR) Followed by Fludarabine Plus Rituximab (FR) and Remission Maintenance Therapy with Rituximab In Previously Untreated B-Chronic Lymphocytic Leukemia (B-CLL): The Chairos AGMT CLL4/Roche ML18434 Study
Authors: Alexander Egle, Lukas Weiss, Thomas Melchardt, Eberhard Gunsilius, Andreas L Petzer, Michael Fridrik, Alois Lang, Otto Krieger, Josef Thaler, Richard Greil
Journal: Blood (2010)
Factors Affecting Allogeneic Peripheral Blood Stem Cell Mobilization in a Large, Ethnically, Diverse Population.
Authors: Sumithira Vasu, Yu Y. Yau, John F. Tisdale, Matthew Hsieh, Richard W. Childs, A. John Barrett, Daniel Fowler, Michael R. Bishop, Elizabeth Kang, Harry L. Malech, Cynthia E. Dunbar, Susan F. Leitman, Charles D. Bolan
Journal: Blood (2007)
A Comparison of 3 Staging Systems for the Outcome Following Autologous Stem Cell Transplantation (ASCT) in Patients with Multiple Myeloma (MM).
Authors: Hee-Jung Sohn, Kihyun Kim, Jae-Hoon Lee, Soo-Mee Bang, Dong Hwan Kim, Je-Jung Lee, Cheolwon Suh
Journal: Blood (2005)
Reversal of Multidrug-Resistance in Human Leukemia Cell Line K562/A02 by Tyrosine Kinase Inhibitors.
Authors: Bao-An Chen, Xue-Yun Shan, Jian Cheng, Feng Gao, Jia-Hua Ding, Chong Gao, Ning-Na Chen, Xiao-Ping Pei, Guo-Hua Xia
Journal: Blood (2009)
A Multi-Institutional Study of Extracorporeal Photoimmune Therapy with UVADEX® for the Prevention of Acute GVHD in Patients Undergoing Standard Myeloablative Conditioning and Allogeneic Hematopoietic Stem Cell Transplantation.
Authors: Paul J. Shaughnessy, Brian J. Bolwell, Sunil Abhyankar, Koen van Besien, Martin Mistrik, Andrew Grigg, Anthony Dodds, H. Miles Prince, Alexandra Machado, Ulrich Thienel, Jim Wang, Francine Foss, Jane Apperley
Journal: Blood (2004)
Regulation of Bone Formation
Authors: Lawrence G. Raisz, Barbara E. Kream
Journal: New England Journal of Medicine (1983)

GlucocorticoidsGlucocorticoids have complex effects on calcium regulation and bone metabolism. Clinically, glucocorticoid excess causes impaired skeletal growth and decreased bone mass.25 Yet it seems likely that glucocorticoids have a physiologic role in regulating bone growth. Glucocorticoid excess decreases the intestinal absorption of calcium and phosphate and increases their renal excretion. These effects can produce secondary hyperparathyroidism and might be expected to produce osteomalacia. However, the osteopenia associated with glucocorticoids is termed osteoporosis because there is no obvious defect in mineralization. This may be because glucocorticoids also inhibit the formation of new matrix, so that wide osteoid seams do not . . .
Umbilical Cord Blood (UCB) Banking: Is Performing the Quality Controls on a Thawed Cryovial Representative of the UCB Graft?.
Authors: Laura Salvaneschi, Cesare Perotti, Paola Bergamaschi, Claudia Del Fante, Gianluca Viarengo, Laura Bellotti T, Cristina Parisi T, Andrea Marchesi T
Journal: Blood (2004)
Hepatosplenic γδ T-Cell Lymphoma Masquerading as T Cell Acute Lymphoblastic Leukemia
Authors: Kunal Sehgal, P. G. Subramanian, Prashant Tembhare, Y. Badrinath, Ashok Kumar, S. D. Banavali, B. Arora, Pratibha Amare Kadam, Sumeet Gujral
Journal: Blood (2008)
Prognostic Impact of Peripheral Blood Involvement during Early Time Points of Childhood ALL Treatment.
Authors: Jana Volejnikova, Eva Fronkova, Ester Mejstrikova, Katerina Muzikova, Leona Reznickova, Dagmar Pospisilova, Jaroslav Sterba, Yahia Jabali, Daniela Prochazkova, Bohumir Blazek, Jiri Hak, Zdenka Cerna, Jan Stary, Jan Trka
Journal: Blood (2008)
Trim58 Is a Putative E3 Ubiquitin Ligase That Functions in Late Stage Erythropoiesis
Authors: Christopher S. Thom, Eugene Khandros, Yu Yao, Jenna M. Nickas, Jacob E. Lazarus, Dolly Prabhu, Olivia Y. Zhou, Erika L.F. Holzbaur, Mitchell J. Weiss
Journal: Blood (2012)
Activated B-Cell DLBCL with Downstream Activation of Survival Signaling Requires PIM Kinase Activity to Maintain Oncoprotein Translation
Authors: Tara L. Peters, Ana A Tula-Sanchez, Lingxiao Li, Praechompoo Pongtornpipat, Mengdie WANG, Nicolette BROWN, Soham D. Puvvada, Jonathan H. Schatz
Journal: Blood (2014)
Single-chromosome Gains Commonly Function as Tumor Suppressors
Authors: Jason M. Sheltzer, Julie H. Ko, John M. Replogle, Nicole C. Habibe Burgos, Erica S. Chung, Colleen M. Meehl, Nicole M. Sayles, Verena Passerini, Zuzana Storchova, Angelika Amon
Journal: Cancer Cell (2017)

Highlights•Single-chromosome gains inhibit anchorage-independent growth and xenograft formation•P53 loss and Ras activation fail to normalize the fitness of trisomic cells•Trisomic cells acquire additional karyotype changes during prolonged growth•Trisomic cells can evolve over time to a higher-fitness stateSummaryAneuploidy is a hallmark of cancer, although its effects on tumorigenesis are unclear. Here, we investigated the relationship between aneuploidy and cancer development using cells engineered to harbor single extra chromosomes. We found that nearly all trisomic cell lines grew poorly in vitro and as xenografts, relative to genetically matched euploid cells. Moreover, the activation of several oncogenic pathways failed to alleviate the fitness defect induced by aneuploidy. However, following prolonged growth, trisomic cells acquired additional chromosomal alterations that were largely absent from their euploid counterparts and that correlated with improved fitness. Thus, while single-chromosome gains can suppress transformation, the genome-destabilizing effects of aneuploidy confer an evolutionary flexibility that may contribute to the aggressive growth of advanced malignancies with complex karyotypes.
A Prospective Study of the Prognostic Impact of 18[F]-FDG-PET and Molecular Response in Patients with Relapsed Indolent Non-Hodgkin Lymphoma (NHL) Following Iodine-131-Rituximab Radio-Immunotherapy (RIT).
Authors: Mark J. Bishton, Rod Hicks, David Alan Westerman, Miles Prince, Max Wolf, John Francis Seymour
Journal: Blood (2007)
Genetic Influence on Blood Pressure Measured in the Office, Under Laboratory Stress, and During Real Life
Authors: Xiaoling Wang, Xiuhua Ding, Shaoyong Su, Gregory Harshfield, Frank Treiber, Harold Snieder
Journal: Circulation (2009)

To determine to what extent the genetic influences on blood pressure (BP) measured in the office, under psychologically stressful conditions in the laboratory and during real life are different from each other. Office BP, BP during a video game challenge and a social stressor interview, and 24-h ambulatory BP were measured in 238 European American and 186 African American twins. BP values across the two tasks were averaged to represent stress levels. Genetic model fitting showed no ethnic or gender differences for any of the measures. The model fitting resulted in heritability estimates of 63, 75 and 71% for office, stress and 24-h systolic BP (SBP) and 59, 67 and 69% for diastolic BP (DBP), respectively. Up to 81% of the heritability of office SBP and 71% of office DBP were attributed to genes that also influenced stress BP. However, only 45% of the heritability of 24-h SBP and 49% of 24-h DBP were attributed to genes that also influence office BP. Similarly, about 39% of the heritability of 24-h SBP and 42% of 24-h DBP were attributed to genes that also influence stress BP. Substantial overlap exists between genes that influence BP measured in the office, under laboratory stress and during real life. However, significant genetic components specific to each BP measurement also exist. These findings suggest that partly different genes or sets of genes contribute to BP regulation in different conditions.
A Six-Month Regimen of Oral Clarithromycin Is a Feasible and Active Therapy for Patients with Relapsed/Refractory Marginal Zone B-Cell Lymphoma of MALT-Type
Authors: Andres JM Ferreri, Giuseppina Patrizia Dognini, Roberto Crocchiolo, Silvia Govi, Giada Licata, Maurilio Ponzoni, Antonio Giordano Resti, Letterio Salvatore Politi, Alberto Rosso, Eugenio Villa
Journal: Blood (2008)
Serum Levels of OPG and MIP-1α in Untreated Multiple Myeloma Patients. Correlations with Staging, Survival and Bone Disease.
Authors: Argyro Papadogiannis, Marie-Cristine Kyrtsonis, Theodoros P. Vassilakopoulos, Tatiana Tzenou, Antonios G. Antoniadis, Christina Kalpadakis, Sotirios Sachanas, Maria N. Dimopoulou, Marina P. Siakantaris, Styliani I. Kokoris, Evangelia M. Dimitriadou, Maria K. Angelopoulou, Eleni Plata, Panagiotis Tsaftaridis, Gerassimos Pangalis
Journal: Blood (2005)
Aberrant Phenotype of blasts in Low and Intermediate-1 Risk Myelodysplastic syndromes Predicts Response of Growth Factor Treatment. a Prospective clinical Phase-II Study.
Authors: Maurice JDL van der Vorst, Theresia M Westers, Martine ED Chamuleau, Corien Eeltink, Gert J Ossenkoppele, Arjan A van de Loosdrecht
Journal: Blood (2008)
Effect of Obesity and Renal Insufficiency On Toxicity of High-Dose Melphalan for Multiple Myeloma.
Authors: Dan T. Vogl, Thomas M. Paul, Eric Stoopler, German Salazar, Lisa Davis, Shiv Kapoor, Babette Zemel, Mark Yudkoff, Gail Jackson, Lisa Basel-Brown, Kenneth Rockwell, Evgueni Daikhin, Cezary R. Swider, John Washington, Maria Raguza-Lopez, Thomas Tenhave, Edward A. Stadtmauer
Journal: Blood (2009)
Australian health minister resigns amid scandal over expense claims
Authors: Paul Smith
Journal: BMJ (2017)

Sussan Ley, Australia’s federal health minister, resigned on 14 January after a week of media headlines about her parliamentary expenses which included charging taxpayers for attending two New Year’s parties with one of Australia’s richest women, Sarina Russo.

A qualified pilot, Ley also allegedly flew herself between cities on two occasions, charging taxpayers more than $A13 000 (£8000; €9100; $9700) when business class tickets would have cost around $A800 each.

It also emerged that during a ministerial trip in 2016—again funded by taxpayers—she had bought an apartment for $A800 000 from a party donor.

Ley, the daughter of a …
Re: Pascal Rischmann, Albert Gelet, Benjamin Riche, et al. Focal High Intensity Focused Ultrasound of Unilateral Localized Prostate Cancer: A Prospective Multicentric Hemiablation Study of 111 Patients. Eur Urol 2017;71:267–73
Authors: Thomas Zilli, Gilles Créhange, Olivier Chapet
Journal: European Urology (2017)
Severe hypercapnia and outcome of mechanically ventilated patients with moderate or severe acute respiratory distress syndrome
Authors: Nicolas Nin, Alfonso Muriel, Oscar Peñuelas, Laurent Brochard, José Angel Lorente, Niall D. Ferguson, Konstantinos Raymondos, Fernando Ríos, Damian A. Violi, Arnaud W. Thille, Marco González, Asisclo J. Villagomez, Javier Hurtado, Andrew R. Davies, Bin Du, Salvatore M. Maggiore, Luis Soto, Gabriel D’Empaire, Dimitrios Matamis, Fekri Abroug, Rui P. Moreno, Marco Antonio Soares, Yaseen Arabi, Freddy Sandi, Manuel Jibaja, Pravin Amin, Younsuck Koh, Michael A. Kuiper, Hans-Henrik Bülow, Amine Ali Zeggwagh, Antonio Anzueto, Jacob I. Sznajder, Andres Esteban
Journal: Intensive Care Medicine (2017)
Myocardial Infarction With Moyamoya Disease and Pituitary Gigantism in a Young Female Patient
Authors: Young Keun Ahn, Myung Ho Jeong, Hee Seung Bom, Jong Chun Park, Jae Kyu Kim, Dong Jin Chung, Min Young Chung, Jeong Gwan Cho, Jung Chaee Kang
Journal: Circulation (1999)

Myocardial infarction is very rare in young female patients with systemic vascular disorders. Moyamoya disease is a cerebrovascular disease associated with an abnormal vascular network. This report presents a 19-year-old female patient who suffered from chest pain and exertional dyspnea for 2 months prior to admission. She had a history of Moyamoya disease and pituitary gigantism since childhood. Her ejection fraction on echocardiogram was 20% and a perfusion defect with partial reversibility in the anterior wall was demonstrated on stress single photon emission computed tomography (SPECT). Diagnostic coronary angiogram revealed critical stenosis in the middle left anterior descending artery, which was treated by coronary stenting. Her subjective symptoms were relieved and the perfusion defect seen on SPECT decreased after coronary intervention. (Jpn Circ J 1999; 63: 644 - 648)
Coronary Calcification Detected by Electron-Beam Computed Tomography and Coronary Heart Disease: The Rotterdam Study.
Authors: Rozemarijn Vliegenthart, Matthijs Oudkerk, Bin Song, Pim J de Feyter, Deirdre AM van der Kuip, Albert Hofman, Jacqueline CM Witteman
Journal: Circulation (2001)

P22 We examined the association between coronary calcification detected by electron-beam computed tomography (EBT) and the presence of myocardial infarction, stratified for gender and age. We performed a cross-sectional study among elderly subjects, participants from the population-based Rotterdam study. Baseline data were collected in 1990-1993. During the third examination phase (1998-2000), subjects were invited for EBT scanning to detect coronary calcification. Calcified lesions were quantified according to Agatston’s method. Calcium scores were available for 1874 of 2263 subjects who underwent EBT scanning. A history of myocardial infarction was defined as the occurrence of a myocardial infarction before baseline or during follow-up but before EBT scanning.Mean age (SD) of the 997 women and 877 men was 71 (5.7) years. The calcium score showed a graded association with the presence of myocardial infarction. Compared to the lowest calcium score category (0 - 100), the age-adjusted odds ratio for myocardial infarction in subjects with calcium score &gt; 2000 was 9.2 (95% CI 4.7 - 18.3) for men, and 10.0 (95% CI 3.4 - 29.8) for women. Additional adjustment for cardiovascular risk factors hardly changed the estimates. The association remained present in subjects above 70 years of age. In conclusion, in this population-based study, a strong association between coronary calcification and myocardial infarction was present in both men and women, which remained present at high age. Although results from prospective data in unselected populations have to be awaited, this study suggests that EBT is a promising tool for the detection of subjects at high-risk of coronary events in the general population.
Bone Marrow (BM) Minimal Residual Disease (MRD) at End of Induction and Interim Maintenance Is Highly Predictive of Outcome in Children with Standard Risk (SR) Acute Lymphoblastic Leukemia (ALL) Treated on the Children’s Oncology Group Study 1991
Authors: Yousif Matloub, Paul S. Gaynon, Somasundaram Jayabose, Bruce C. Bostrom, Stephen P. Hunger, Anne L Angiolillo, Meenakshi Devidas, Stephen Linda, William L. Carroll, Naomi Winick, Harland Sather, Sharon R Pine
Journal: Blood (2008)
Concordance Between Clinical and Histopathological Diagnoses of Corneal Specimens
Authors: Christopher K.H. Burris, Amir A. Azari, Ralph C. Eagle, Christopher J. Rapuano, Deniz Marangoz, Heather D. Potter, Kyungmann Kim, Bradley Thuro, Paul O. Phelps, Krishna Surapaneni, Maria E. Rodriguez, Meisha L. Raven, Vivian Lee, Mausam R. Damani, Mark Carey, Mozhgan R. Kanavi, Mohammad A. Javadi, Daniel M. Albert
Journal: Ophthalmology (2017)
Role of Allogeneic Hematopoietic Stem Cell Transplantation for None Remission / Advanced Acute Myeloid Leukemia with Flt3-Itd Mutations: Outcomes of 15 Newly Diagnosed Patients from a Single Institution
Authors: Zhiping Fan, Qifa Liu, Jing Sun, Yu Zhang, Fen Huang, Qianli Jiang, Hongsheng Zhou, Yongqiang Wei
Journal: Blood (2014)
<i>Notes from the Field</i>: Occupational Lead Exposures at a Shipyard — Douglas County, Wisconsin, 2016
Authors: Debora Weiss, Stephanie J. Yendell, Luke A. Baertlein, Krista Y. Christensen, Carrie D. Tomasallo, Paul D. Creswell, Jenny L. Camponeschi, Jon G. Meiman, Henry A. Anderson
Journal: MMWR Morbidity and Mortality Weekly Report (2017)
The Relation of Clinical Response and Minimal Residual Disease and Their Prognostic Impact On Outcome in Acute Myeloid Leukemia
Authors: Xueyan Chen, Hu Xie, Carl Bohm, Brent L. Wood, John M. Pagel, Pamela S. Becker, Roland B. Walter, Ravinder K Sandhu, Janis L Abkowitz, Frederick R. Appelbaum, Elihu H. Estey
Journal: Blood (2012)
Trends in Ferritin Can Be Dramatically Different From Trends in Total Body Iron and Could Lead to Erroneous Decisions in Iron Chelation Management and Discourage Adherence in Chronically Transfused Patients,
Authors: Mammen Puliyel, Adam Bush, Vasilios Berdoukas, Thomas Hofstra, Susan Claster, Bhakti P. Mehta, Anne Nord, Susan Carson, Tatiana Hernandez, Ani Dongelyan, John C Wood, Thomas D. Coates
Journal: Blood (2011)